Deep Learning of Urine Stem Cell Mitochondria in Alzheimer’s
2026-05-07
This study pioneers a non-invasive approach to Alzheimer’s disease biomarker discovery by applying deep learning to live urine-derived stem cell mitochondrial morphology. The framework enables dynamic, patient-specific assessment of mitochondrial dysfunction, potentially transforming early AD detection and monitoring.
BODIPY 581/591 C11: Reliable Ratiometric Lipid Peroxidation
2026-05-06
This article addresses real-world laboratory challenges in oxidative stress and lipid peroxidation assays, demonstrating how BODIPY 581/591 C11 (SKU C8003) provides sensitive, reproducible, and practical solutions. Through scenario-driven Q&A, we highlight workflow optimization, data interpretation, and evidence-based vendor selection for researchers evaluating oxidative stress and antioxidant capacity.
Mianserin HCl: Translational Leverage in Antidepressant Rese
2026-05-06
This thought-leadership article offers a multidimensional perspective on Mianserin Hydrochloride (Mianserin HCl), highlighting its role as a 5-HT2 receptor antagonist and its strategic value for translational neuroscience, psychiatric disorder research, and emerging antipathogenic applications. Anchored in both seminal clinical evidence and advanced mechanistic insight, this piece transcends conventional product summaries, providing actionable guidance and a visionary outlook for researchers seeking to harness the full potential of APExBIO’s high-purity Mianserin HCl.
Neomycin Sulfate: Precision Tool for RNA/DNA and Ion Channel
2026-05-05
Neomycin sulfate’s dual action as a nucleic acid stabilizer and ion channel blocker makes it indispensable for advanced molecular biology workflows. Explore experimental protocols, troubleshooting, and translational insights that harness its mechanistic specificity across research domains.
TRIM66 and the Epigenetic Control of Monogenic Olfactory Rec
2026-05-05
This study identifies TRIM66 as a pivotal epigenetic repressor governing the monogenic expression of olfactory receptors in sensory neurons. By uncovering TRIM66's role in silencing all but one receptor gene per neuron, the research advances our understanding of neural specificity and has meaningful implications for epigenetic regulation in sensory systems.
Phosphatase Inhibitor Cocktail 3: Precision in Phosphoprotei
2026-05-04
Phosphatase Inhibitor Cocktail 3 (100X in DMSO) delivers robust, broad-spectrum serine/threonine phosphatase inhibition, safeguarding protein phosphorylation during extraction and analysis. Explore advanced workflows, troubleshooting strategies, and the latest research insights that distinguish this APExBIO solution for rigorous phosphoprotein studies.
SLC25A1 Drives Cisplatin Resistance in HNSCC via Senescence
2026-05-04
Li et al. demonstrate that upregulation of SLC25A1 in head and neck squamous cell carcinoma (HNSCC) induces chemoresistance to cisplatin by promoting cellular senescence through H3K27 acetylation–mediated gene activation. These insights identify SLC25A1 as both a predictive biomarker and a candidate therapeutic target for overcoming cisplatin resistance in HNSCC.
BicD and MAP7 Synergize to Activate Drosophila Kinesin-1
2026-05-03
This study uncovers how the adaptor protein BicD and the microtubule-associated protein MAP7 jointly activate homodimeric Drosophila kinesin-1 through distinct but complementary mechanisms. The findings clarify adaptor-mediated relief of kinesin auto-inhibition and highlight the interplay between cargo adaptors and microtubule-binding proteins in intracellular transport regulation.
PP2A-Regulated Autophagy Drives Drug Resistance in C. albica
2026-05-02
This study identifies protein phosphatase 2A (PP2A) as a key regulator of autophagy-mediated drug resistance in Candida albicans biofilms. By dissecting the molecular mechanism involving ATG protein phosphorylation, the research reveals new therapeutic entry points for managing biofilm-associated antifungal resistance.
Demethyleneberberine Inhibits NF-κB/MAPK to Attenuate Hepati
2026-05-02
This study demonstrates that Demethyleneberberine (DMB), a natural isoquinoline alkaloid, attenuates concanavalin A-induced autoimmune hepatitis in mice by inhibiting NF-κB and MAPK signaling. The findings highlight DMB’s mechanistic action on inflammatory pathways, positioning it as a promising tool for autoimmune hepatitis research and pathway-targeted disease modeling.
Tofacitinib Citrate in Immune Modulation: Mechanisms and Str
2026-05-01
This thought-leadership article explores the mechanistic and strategic landscape of tofacitinib citrate (CP-690550 citrate) in immune regulation and inflammatory disorder research. Integrating recent findings on cardiovascular safety and endothelial cell function, it provides translational researchers with actionable guidance for dissecting JAK-STAT signaling, optimizing experimental design, and responsibly modeling disease with APExBIO’s trusted reagent.
Disrupting Tumor pH Homeostasis with Biomimetic Microparticl
2026-04-30
This study introduces a biomimetic microparticle system that disrupts both intracellular and extracellular pH balance in tumor cells. By targeting lactate export and activating immunogenic cell death, the approach synergizes chemotherapy and immunotherapy for enhanced tumor suppression.
DAPT (GSI-IX): Applied Protocols in Notch and APP Research
2026-04-30
DAPT (GSI-IX) stands out as a selective γ-secretase inhibitor, empowering researchers to dissect Notch signaling and amyloid precursor protein processing across neurodegeneration, oncology, and regenerative science. This guide translates recent cell culture breakthroughs and disease model strategies into actionable protocols, troubleshooting advice, and advanced workflow integrations.
Spleen-Targeted Neoantigen mRNA Vaccine Drives TLS in HCC
2026-04-29
This study demonstrates that a spleen-targeted neoantigen mRNA vaccine (STNvac) elicits potent antitumor immunity in hepatocellular carcinoma (HCC) by activating ISG15+ CD8+ T cells and promoting tertiary lymphoid structure (TLS) formation. The results highlight the mechanistic importance of GZMA-F2R signaling in this process and suggest new avenues for mRNA vaccine optimization in immunologically cold tumors.
GLP-1 (9-36) Amide: Precision Antagonism for Translational I
2026-04-29
This article examines the mechanistic and translational power of GLP-1 (9-36) amide as a benchmark tool for dissecting GLP-1 receptor signaling, with an emphasis on recent evidence exposing receptor cross-reactivity and the strategic implications for metabolic disease research. It delivers actionable guidance for researchers aiming to optimize their experimental design and interpret complex GPCR interplay, while differentiating the discussion from standard product pages by integrating cross-study insights and forward-looking perspectives.
466 records 20/32 page Previous Next First page 上5页 1617181920 下5页 Last page